The global Cell Proliferation Kit Market is expected to foresee significant growth. North America to lead the growth!
- Himanshu Patni
- February 10, 2023
- HEALTHCARE, NEWS
- Cell Proliferation Kit Market, Cell Proliferation Kit Market Growth, Cell Proliferation Kit Market Share, Cell Proliferation Kit Market Size, Cell Proliferation Kit Market Trends
- 0 Comments
The global cell proliferation kit market is expected to register a CAGR of approx. 7% over the period of 2022-2028. Cell replication, or the process of cell proliferation, is essential for maintaining the homeostasis of adult tissues by replacing dead cells with fresh ones. This process begins during embryogenesis. Abnormal cell proliferation is seen in a few disease conditions, such as cancer. So, in both in vitro and in vivo settings, cell proliferation assay kits gained popularity in the clinical diagnosis of various disease indications. These are used in research studies of cell activation, cytotoxicity assessment, and clinical trials to determine therapeutic efficacy. The global cell proliferation kit market is growing due to the surge in demand for various types of cytotoxic drugs and medication, and technological advancement in assay techniques which boosts the adoption of inorganic growth strategies among key industry players around the globe. For instance, in March 2022, Promega Corp. and Fujifilm Cellular Dynamics, Inc., signed a collaboration for a novel assay development program for drug discovery purposes. Owing to these glaring statistics the demand for cell proliferation kits is anticipated to grow in the forthcoming years as the increasing volume of patients suffering from various types of cancer as well as new increasing new variations in diseases boosted the growth of the cell proliferation kit industry. Moreover, rising healthcare awareness is fueling the demand for the cell proliferation kit market. Furthermore, growth in awareness regarding nutritional products and awareness about the advantages of cell proliferation kits over other techniques are expected to drive the market for the cell proliferation kit market in the coming years.
For a detailed analysis of the Global Cell Proliferation Kit Market browse through – https://univdatos.com/report/cell-proliferation-kit-market/
Based on the type, the cell proliferation kit market is segmented into fluorometric cell viability kits, colorimetric cell viability kits, bioluminescent cell viability kits, and others. The colorimetric cell viability kits segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe. This method for detecting cell viability is cost-effective and easy to retrieve throughout data. It is also anticipated that the widespread use of this technique to identify various cellular activities, such as DNA synthesis, metabolic activity, and ATP production, will spur the expansion of the future market segment.
Based on the application, the market is fragmented into pharmaceutical and biotechnology companies, academic institutes and research laboratories, and others. The pharmaceutical and biotechnology companies segment grabbed a considerable market share and is expected to grow at a significant CAGR during the forecast period. Cell proliferation kits are used in academic institutions and research labs to identify cell damage by monitoring how the cells respond to various stimuli, such as hydrogen peroxide, antibiotics, etc.
Request for Sample of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=34272
For a better understanding of the market adoption of the cell proliferation kit, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the cell proliferation kit industry owing to the growing number of new cancer cases like melanoma, urothelial carcinoma, lung cancer, and others each year in the region. Moreover, the presence of well-established healthcare facilities, growing advanced technologies, as well as rising healthcare spending boost the market growth in this region. For instance, according to centers for medicare & medicaid services, U.S. healthcare spending grew 2.7% in 2021, reaching USD 4.3 trillion or USD 12,914 per person. As a share of the nation’s Gross Domestic Product, health spending accounted for 18.3%.
Some of the major players operating in the market include Thermo Fisher Scientific Inc, Merck KGaA, GE Healthcare, PerkinElmer Inc, Bio-Rad Laboratories, Inc., Becton Dickinson and Co, Biotium, Agilent Technologies Inc, F. Hoffmann-La Roche AG, Biological Industries.
Global Cell Proliferation Kit Market Segmentation
Market Insight, by Type
· Fluorometric Cell Viability Kits
· Colorimetric Cell Viability Kits
· Bioluminescent Cell Viability Kits
· Others
Market Insight, by Application
· Pharmaceutical and Biotechnology Companies
· Academic Institutes and Research Laboratories
· Others
Market Insight, by Region
· North America
o United States
o Canada
o Rest of North America
· Europe
o France
o Germany
o Italy
o Spain
o United Kingdom
o Rest of Europe
· Asia-Pacific
o China
o India
o Australia
o Japan
o Rest of Asia-Pacific
· Rest of World
Top Company Profiles
· Thermo Fisher Scientific Inc
· Merck KGaA
· GE Healthcare
· PerkinElmer Inc
· Bio-Rad Laboratories, Inc.
· Becton Dickinson and Co
· Biotium
· Agilent Technologies Inc
· F. Hoffmann-La Roche AG
· Biological Industries